JOSEPHINE TAFIE: Open Payments
NPI 1871937482 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 13 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $345 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: CAPLYTA, INGREZZA, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
